The NF‐κB signaling pathway is crucial in lung cancer progression, and studies have reported that NAT10 promotes NF‐κB signaling pathway activity in lung cancer, thereby promoting lung cancer progression.123. Here, NFKB1 is linked to lung carcinoma.